Literature DB >> 21415229

Documenting the content of physical therapy for children with acquired brain injury: development and validation of the motor learning strategy rating instrument.

Danielle Levac1, Cheryl Missiuna, Laurie Wishart, Carol Dematteo, Virginia Wright.   

Abstract

BACKGROUND: A goal of physical therapy interventions for children and youth with acquired brain injury (ABI) is the learning and relearning of motor skills. Therapists can apply theoretically derived and evidence-based motor learning strategies (MLSs) to structure the presentation of a task and organize the environment in ways that may promote effective, transfer-oriented practice. However, little is known about how MLSs are used in physical therapy interventions for children with ABI.
OBJECTIVE: The purpose of this study was to develop and validate an observer-rated Motor Learning Strategy Rating Instrument (MLSRI) quantifying the application of MLSs in physical therapy interventions for children with ABI.
DESIGN: A multi-stage, iterative, item generation and reduction approach was used.
METHODS: An initial list of MLS items was generated through literature review. Seven experts participated in face validation to confirm item comprehensiveness. In a content validation process, 12 physical therapists with pediatric ABI experience responded to a questionnaire evaluating feasibility and importance of items. Six physical therapy sessions with clients with ABI were videotaped at a children's rehabilitation center. The 12 physical therapists participated in a session where they: (1) rated session videos to test the MLSRI and (2) provided verbal feedback.
RESULTS: Revisions were made sequentially to the MLSRI based on these processes. LIMITATIONS: The MLSRI was scored during videotape observation rather than being given a live rating, which may be onerous in certain settings and may influence therapist or child behavior.
CONCLUSIONS: Further reliability investigations will determine whether the 33-item MLSRI is of help in documenting strategy use during intervention, as an evaluation tool in research, and as a knowledge transfer resource in clinical practice.

Entities:  

Mesh:

Year:  2011        PMID: 21415229     DOI: 10.2522/ptj.20100415

Source DB:  PubMed          Journal:  Phys Ther        ISSN: 0031-9023


  6 in total

1.  Reliability of the Motor Learning Strategies Rating Instrument in physiotherapy intervention for children with cerebral palsy.

Authors:  Jennifer L Ryan; Danielle E Levac; F Virginia Wright
Journal:  Dev Med Child Neurol       Date:  2019-02-11       Impact factor: 5.449

2.  Exploring Physiotherapists' Use of Motor Learning Strategies in Gait-Based Interventions for Children with Cerebral Palsy.

Authors:  Jennifer L Ryan; F Virginia Wright; Danielle E Levac
Journal:  Phys Occup Ther Pediatr       Date:  2019-06-03       Impact factor: 2.360

3.  How can instructions and feedback with external focus be shaped to enhance motor learning in children? A systematic review.

Authors:  Ingrid P A van der Veer; Evi Verbecque; Eugene A A Rameckers; Caroline H G Bastiaenen; Katrijn Klingels
Journal:  PLoS One       Date:  2022-08-25       Impact factor: 3.752

4.  Promoting Therapists' Use of Motor Learning Strategies within Virtual Reality-Based Stroke Rehabilitation.

Authors:  Danielle E Levac; Stephanie M N Glegg; Heidi Sveistrup; Heather Colquhoun; Patricia Miller; Hillel Finestone; Vincent DePaul; Jocelyn E Harris; Diana Velikonja
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

5.  Advanced virtual reality-based rehabilitation of balance and gait in clinical practice.

Authors:  Desiderio Cano Porras; Hadar Sharon; Rivka Inzelberg; Yitzhak Ziv-Ner; Gabriel Zeilig; Meir Plotnik
Journal:  Ther Adv Chronic Dis       Date:  2019-08-23       Impact factor: 5.091

Review 6.  Physical rehabilitation interventions in children with acquired brain injury: a scoping review.

Authors:  Christiaan Gmelig Meyling; Olaf Verschuren; Ingrid R Rentinck; Raoul H H Engelbert; Jan Willem Gorter
Journal:  Dev Med Child Neurol       Date:  2021-07-26       Impact factor: 4.864

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.